Recombinant Xenopus laevis Tolloid-like protein 2 (tll2), partial

Shipped with Ice Packs
In Stock

Description

Enzymatic Functions

TLL2 exhibits substrate specificity distinct from other BMP1/TLD-like proteases:

SubstrateActivityComparison to Other BMP1/TLD Proteases
Prolysyl oxidase (LOX)Activates LOX zymogen, enabling collagen cross-linking .Shared with BMP1, TLL1, and mTLD .
ChordinCleaves Chordin to regulate BMP signaling dynamics .Less efficient than BMP1 in Chordin processing .
ProcollagenLimited or no activity on procollagen C-propeptides .Contrasts with BMP1, which efficiently cleaves procollagen .

Role in Embryonic Development

TLL2 is critical during Xenopus embryogenesis:

  • Dorsal-ventral patterning: Modulates BMP signaling gradients by processing Chordin-BMP complexes .

  • ECM organization: Facilitates collagen maturation via LOX activation, ensuring tissue integrity .

  • Foregut organogenesis: Indirectly supports BMP signaling loops necessary for liver, pancreas, and lung development .

Loss of TLL2 function disrupts embryonic structures, highlighting its non-redundant role .

Key Studies:

  • Substrate Specificity: Recombinant TLL2 partially retains the ability to cleave Chordin and activate LOX but shows negligible procollagen-processing activity .

  • Regulatory Interactions:

    • BMP4 binds TLL2’s CUB domains, inhibiting its proteolytic activity in a non-competitive manner .

    • Sizzled (Szl), a secreted BMP antagonist, modulates TLL2 activity by stabilizing Chordin-BMP complexes .

  • Developmental Phenotypes:

    • Embryos with TLL2 knockdown exhibit defective ECM deposition and impaired organogenesis .

Experimental Applications:

  • Fluorogenic assays: Used to quantify TLL2’s enzymatic kinetics using synthetic Chordin-derived peptides .

  • Overexpression studies: Demonstrate that mutant TLL2 (e.g., Phe249Leu in BMP1) fails to enhance procollagen processing, confirming functional deficits .

Applications and Implications

  • Biomedical Research: Serves as a tool to study ECM disorders and BMP signaling pathologies.

  • Therapeutic Potential: Targeting TLL2 could modulate fibrosis or metastatic pathways involving LOX .

Unresolved Questions

  • Redundancy: Why does TLL2 retain Chordinase activity but lack procollagen-processing function in Xenopus?

  • Regulatory Mechanisms: How do CUB domain interactions with BMPs fine-tune TLL2 activity in vivo?

Product Specs

Form
Lyophilized powder. We will preferentially ship the in-stock format. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with normal blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tll2; xld; Tolloid-like protein 2; EC 3.4.24.-; Metalloprotease xolloid; Xenopus tolloid
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
tll2
Uniprot No.

Target Background

Function
This protease specifically processes prolysyl oxidase and possibly chordin. It is essential for embryonic development, influencing dorsal-ventral patterning and skeletogenesis. In embryos, it inhibits dorsoanterior structure development and ventralizes activin-induced dorsal mesoderm in animal caps.
Database Links

KEGG: xla:399469

UniGene: Xl.36

Protein Families
Peptidase M12A family
Subcellular Location
Secreted.

Q&A

What is Tolloid-like protein 2 (tll2) and how does it relate to other members of the Tolloid family?

Tolloid-like protein 2 (tll2) is a member of the Tolloid family of metalloproteases that play crucial roles in embryonic patterning and tissue morphogenesis during embryogenesis in both vertebrates and invertebrates. The Tolloid family in vertebrates includes Tolloid/BMP-1, Tolloid-like 1 (Tll-1), and Tolloid-like 2 (Tll-2). While these proteins share similar domain organization, they differ in their substrate specificity and activity. Xenopus laevis tll2 is structurally and functionally related to mammalian Tll-2, containing an astacin-like protease domain, CUB protein-protein interaction domains, and EGF motifs that enable its protease activity and substrate interactions .

What are the primary functions of tll2 in Xenopus laevis development?

Based on studies of Tolloid family members, tll2 in Xenopus laevis likely functions in embryonic development, particularly in processes involving extracellular matrix assembly and growth factor signaling. Similar to other Tolloid proteins, it may be involved in processing extracellular matrix components like procollagen, laminin, and biglycan, as well as in regulating signaling pathways by cleaving antagonists of growth factors such as chordin, the vertebrate homolog of Drosophila SOG (Short Gastrulation) .

How does the domain structure of Xenopus laevis tll2 compare to its mammalian counterparts?

Xenopus laevis tll2 likely shares structural similarities with the characterized mammalian and reptilian Tolloid-like proteins. Based on comparative analysis with the turtle Tolloid (tTll), which is most similar to chicken Tll-2, Xenopus tll2 would be expected to contain an astacin-like protease domain, multiple CUB protein-protein interaction domains, and one or more EGF motifs. It may differ from mammalian Tll-2 in the specific number of CUB and EGF domains, as observed in the turtle Tolloid which has three CUB domains and only one EGF motif, compared to the five CUB domains and two EGF domains found in mammalian Tolloids .

What expression systems are most effective for producing recombinant Xenopus laevis tll2?

For recombinant expression of Xenopus laevis tll2, multiple host systems can be considered, including E. coli, yeast, baculovirus, or mammalian cell expression systems. The choice depends on research requirements for protein folding, post-translational modifications, and activity. For structural studies requiring high yields, E. coli or yeast systems may be preferred, while for functional studies requiring proper folding and post-translational modifications, insect or mammalian cell systems would be more appropriate. Based on protocols for similar proteins like TLL1, expression systems that achieve ≥85% purity as determined by SDS-PAGE would be suitable for most research applications .

How can I optimize the purification of recombinant Xenopus laevis tll2 to maintain its enzymatic activity?

To preserve enzymatic activity during purification of recombinant Xenopus laevis tll2:

  • Include zinc and calcium ions in buffers throughout purification, as Tolloid metalloproteases are zinc and calcium-dependent proteases

  • Maintain pH between 7.0-8.0 to preserve the metalloprotease domain structure

  • Consider using affinity chromatography followed by size-exclusion chromatography to achieve high purity

  • Minimize freeze-thaw cycles and store with glycerol (10-20%) at -80°C

  • Include protease inhibitors during purification to prevent self-degradation

  • Test enzymatic activity directly after purification using known substrates such as chordin or procollagen

What are the critical factors affecting solubility of recombinant tll2 during expression?

Critical factors affecting solubility during expression of recombinant tll2 include:

  • Expression temperature (lower temperatures like 16-18°C often increase solubility)

  • Induction conditions (IPTG concentration and timing for bacterial systems)

  • Presence of proper folding chaperones

  • Codon optimization for the expression host

  • Inclusion of solubility tags (such as MBP, SUMO, or Thioredoxin)

  • Expression of partial constructs focusing on specific domains rather than the full-length protein

  • Buffer composition during cell lysis (including appropriate salts, detergents, and stabilizing agents)

Testing these variables systematically can significantly improve solubility yields for functional studies .

What are the established substrates for Xenopus laevis tll2 and how can substrate specificity be determined?

Based on studies of Tolloid family proteins, potential substrates for Xenopus laevis tll2 likely include:

  • Chordin - a BMP antagonist crucial for developmental patterning

  • Extracellular matrix components - procollagen, laminin, and biglycan

  • Latent TGFβ-binding protein-1 - involved in TGFβ signaling regulation

To determine substrate specificity:

  • Conduct in vitro cleavage assays with purified recombinant tll2 and candidate substrates

  • Use fluorescence resonance energy transfer (FRET) peptides containing potential cleavage sites

  • Perform proteomic analysis of culture media from cells expressing tll2 versus control cells

  • Analyze cleavage patterns by mass spectrometry to identify precise cutting sites

  • Compare cleavage efficiency with other Tolloid family members to establish relative specificities

How does the enzymatic activity of tll2 compare to other Tolloid family members in Xenopus?

While specific comparative data for Xenopus tll2 is not directly available in the search results, studies of mammalian Tolloid family members indicate that despite structural similarities, these proteins exhibit different substrate preferences and catalytic efficiencies. Based on mammalian studies, we would expect:

  • Different cleavage rates for shared substrates like chordin

  • Variation in metalloprotease domain activity related to differences in the metal-binding site

  • Differential regulation by enhancer proteins such as Twisted gastrulation (Tsg)

  • Distinct multimerization patterns affecting substrate accessibility and catalytic efficiency

Experimental comparative analysis using standardized substrates and conditions would be necessary to precisely determine the relative activities of Xenopus tll2 versus other family members like tll1 .

What cofactors or enhancers modulate tll2 activity in developmental contexts?

Based on studies of Tolloid family proteins, several factors likely modulate tll2 activity:

  • Twisted gastrulation (Tsg) - enhances cleavage of chordin substrates, potentially by inducing conformational changes in chordin rather than directly interacting with the protease

  • Calcium and zinc ions - essential cofactors for metalloprotease activity

  • Olfactomedin 1 (ONT1) - may act as a negative regulator

  • Secreted frizzled-related protein 2 (sFRP2) - could function as a context-dependent regulator

  • Procollagen C-endopeptidase enhancer-1 (PCPE-1) - enhances cleavage of procollagen substrates

Testing these interactions specifically with Xenopus tll2 would provide insights into its regulation during developmental processes .

What are effective strategies for studying tll2 function in Xenopus embryonic development?

To study tll2 function in Xenopus development:

  • Knockdown approaches:

    • Morpholino oligonucleotides targeting tll2 mRNA

    • CRISPR/Cas9-mediated gene editing to generate tll2 mutants

  • Gain-of-function approaches:

    • Microinjection of synthetic tll2 mRNA into embryos

    • Targeted expression using tissue-specific promoters

  • Rescue experiments:

    • Co-injection of wild-type or mutant tll2 constructs with knockdown reagents

    • Domain-swap experiments to identify functional regions

  • Visualization techniques:

    • In situ hybridization to characterize expression patterns

    • Immunohistochemistry with tll2-specific antibodies

    • Fluorescent fusion proteins to track localization

Xenopus laevis offers significant advantages for these studies as embryos are easily manipulated, develop externally, and provide sufficient material for biochemical analysis .

How can I design experiments to distinguish between direct and indirect tll2 substrates in vivo?

To distinguish between direct and indirect tll2 substrates:

  • In vitro validation:

    • Incubate purified recombinant tll2 with candidate substrates

    • Analyze cleavage products by SDS-PAGE and Western blotting

    • Identify precise cleavage sites by mass spectrometry

  • In vivo approaches:

    • Create catalytically inactive tll2 mutants (by mutating the metal-binding HEXXH motif)

    • Express wild-type vs. inactive tll2 in Xenopus embryos

    • Compare proteolytic processing of candidate substrates

    • Use proximity labeling techniques (BioID or APEX) to identify proteins in close association with tll2

  • Temporal analysis:

    • Track the kinetics of substrate cleavage after controlled activation of tll2

    • Use pulsed expression systems to distinguish primary from secondary effects

  • Domain-specific interactions:

    • Create chimeric proteins with domain swaps between different Tolloid family members

    • Test substrate specificity to map interaction domains

What techniques can be employed to investigate tll2 multimerization and its impact on substrate recognition?

To investigate tll2 multimerization and its effects on substrate recognition:

  • Biochemical approaches:

    • Size-exclusion chromatography to determine native molecular weight

    • Chemical cross-linking followed by SDS-PAGE to capture transient complexes

    • Analytical ultracentrifugation to determine oligomerization state

    • Blue native PAGE to preserve native protein complexes

  • Structural biology techniques:

    • Cryo-electron microscopy of purified complexes

    • X-ray crystallography of tll2 alone or with substrates

    • Small-angle X-ray scattering (SAXS) to determine solution structure

  • Protein-protein interaction methods:

    • Fluorescence resonance energy transfer (FRET) between differentially labeled tll2 molecules

    • Bioluminescence resonance energy transfer (BRET) for in vivo studies

    • Split-reporter assays (like split-GFP) to detect dimerization

  • Functional analysis:

    • Create obligate monomers or dimers through mutation of interaction interfaces

    • Compare catalytic efficiency of engineered variants

    • Use domain deletion mutants to map regions involved in multimerization

These approaches can reveal whether tll2 forms tetramers like the related Tol2 transposase or adopts different oligomeric states affecting its substrate preferences .

How can inconsistent results in tll2 activity assays be resolved when using different expression systems?

When encountering inconsistent results in tll2 activity assays across different expression systems:

  • Standardize protein quality assessment:

    • Verify intact protein by mass spectrometry

    • Check zinc and calcium content by atomic absorption spectroscopy

    • Assess proper folding using circular dichroism

    • Compare specific activity against a standard substrate

  • Address system-specific modifications:

    • Analyze post-translational modifications by mass spectrometry

    • Compare glycosylation patterns when using mammalian versus insect cells

    • Identify proteolytic processing that may differ between systems

  • Optimize assay conditions:

    • Systematically test buffer compositions, pH ranges, and ion concentrations

    • Evaluate temperature and time-course dependencies

    • Include appropriate controls with known activity

  • Data normalization strategies:

    • Normalize activity to active site titration rather than total protein

    • Develop quantitative activity standards

    • Use relative rather than absolute comparisons when comparing across systems

These approaches can help resolve discrepancies and establish reliable protocols for consistent activity measurements .

What statistical approaches are most appropriate for analyzing developmental phenotypes in tll2 knockdown/knockout studies?

For analyzing developmental phenotypes in tll2 manipulation studies:

  • Categorical data analysis:

    • Chi-square tests for phenotypic categories (normal, mild, severe)

    • Fisher's exact test for small sample sizes

    • Ordinal logistic regression for graded phenotypes

  • Quantitative measurements:

    • ANOVA with post-hoc tests for comparing multiple groups

    • t-tests (paired or unpaired) for direct comparisons between two conditions

    • Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis) when normality cannot be assumed

  • Developmental timing analysis:

    • Survival analysis methods (Kaplan-Meier, Cox regression) for developmental milestone timing

    • Mixed-effects models for longitudinal measurements

  • Sample size considerations:

    • Power analysis to determine appropriate embryo numbers

    • Biological replicates (multiple clutches) to account for clutch-to-clutch variation

    • Technical replicates to control for experimental variation

  • Controls and validation:

    • Include rescue experiments as positive controls

    • Use multiple knockdown/knockout approaches to confirm specificity

    • Document dose-response relationships to strengthen causal inferences

These statistical approaches help ensure robust interpretation of developmental phenotypes in Xenopus studies .

How should researchers address contradictory findings between tll2 studies in Xenopus and other model organisms?

When addressing contradictory findings between tll2 studies across species:

  • Evolutionary context analysis:

    • Compare protein sequence conservation, especially in functional domains

    • Analyze synteny and gene duplication events that may have led to subfunctionalization

    • Consider the whole Tolloid family complement in each species

  • Methodological reconciliation:

    • Evaluate differences in experimental approaches (knockout vs. knockdown)

    • Compare developmental timing of manipulations

    • Assess dosage considerations and potential compensation mechanisms

  • Context-dependent function:

    • Investigate tissue-specific differences in expression or regulation

    • Examine interacting protein availability across species

    • Consider redundancy with other Tolloid family members

  • Direct comparative studies:

    • Perform cross-species rescue experiments

    • Test orthologous substrates from different species

    • Use heterologous expression in a neutral cellular background

  • Integrative analysis:

    • Develop models that accommodate species-specific differences

    • Identify core conserved functions versus derived specializations

    • Consider ecological and evolutionary adaptations that might drive functional divergence

This systematic approach can help reconcile seemingly contradictory findings and identify genuine biological differences versus technical artifacts .

How has the tll2 gene evolved across vertebrates and what insights does this provide for Xenopus research?

The evolution of tll2 across vertebrates reveals important insights:

  • Sequence conservation:

    • The astacin-like protease domain shows the highest conservation across species

    • The metal-binding HEXXH motif is virtually identical between turtle, avian, and mammalian Tll2

    • CUB and EGF domains show more evolutionary flexibility in number and arrangement

  • Domain architecture differences:

    • Mammalian Tll2 typically contains five CUB domains and two EGF domains

    • Reptilian Tll (most similar to Tll2) has three CUB domains and only one EGF motif

    • These differences likely affect substrate specificity and interaction capabilities

  • Functional implications:

    • Core proteolytic functions appear conserved across vertebrates

    • Species-specific adaptations may reflect differences in developmental programs

    • Xenopus tll2 likely represents an intermediate evolutionary stage between fish and mammals

  • Expression pattern evolution:

    • Mammalian Tll2 shows highest expression in the cerebellum with lower levels in brain stem and cortex

    • Similar expression patterns observed in reptiles suggest conserved neurological functions

    • Comparative expression analysis in Xenopus would provide valuable evolutionary context

Understanding these evolutionary relationships helps predict functional conservation and divergence, guiding experimental design in Xenopus research .

What differences exist between tll2 expression patterns and functional roles in Xenopus laevis versus Xenopus tropicalis?

While specific comparative data between Xenopus species is not available in the search results, important considerations for comparing tll2 between X. laevis and X. tropicalis include:

  • Genome duplication effects:

    • X. laevis is allotetraploid with potentially duplicated tll2 genes (tll2.L and tll2.S homeologs)

    • X. tropicalis is diploid with a single tll2 gene

    • Homeolog subfunctionalization may have occurred in X. laevis, leading to different expression patterns or functions

  • Developmental timing differences:

    • X. tropicalis develops faster than X. laevis

    • This may affect temporal expression windows and developmental functions of tll2

  • Experimental advantages:

    • X. tropicalis offers simpler genetics for loss-of-function studies

    • X. laevis provides more embryonic material for biochemical analyses

    • Complementary studies in both species can provide robust validation

  • Research considerations:

    • Use gene-specific primers to distinguish homeologs in X. laevis

    • Consider potential redundancy or compensation between homeologs

    • Design cross-species rescue experiments to test functional conservation

Systematic comparison of expression patterns and functions between these closely related species could reveal important insights into evolutionary adaptation and functional constraints of tll2 .

How do the kinetic properties of recombinant Xenopus tll2 compare with mammalian and other vertebrate orthologs?

A comprehensive comparison of kinetic properties would include:

PropertyXenopus laevis tll2Mammalian Tll2Avian Tll2Fish Tll2
kcat for chordin cleavage[Requires empirical determination]Moderate efficiency[Limited data][Limited data]
KM for chordin binding[Requires empirical determination]Species-specific variations[Limited data][Limited data]
Calcium dependenceLikely high, based on conserved structureHighHighHigh
pH optimumPredicted 7.0-8.07.5-8.0[Limited data][Limited data]
Temperature stabilityLikely optimized for poikilotherm physiologyOptimized for 37°COptimized for avian body temperatureSpecies-dependent
Enhancer responsivenessPredicted interaction with Xenopus TsgEstablished interaction with Tsg[Limited data][Limited data]
Multimerization state[Requires empirical determination]Forms multimeric complexes[Limited data][Limited data]

To establish these parameters for Xenopus tll2:

  • Express and purify recombinant proteins from all species under identical conditions

  • Use standardized substrates and assay conditions

  • Perform side-by-side kinetic measurements

  • Analyze temperature dependence across physiologically relevant ranges

  • Test cross-species enhancer interactions

This systematic comparison would reveal evolutionary adaptations and provide insights into structure-function relationships across vertebrate lineages .

How can recombinant tll2 be utilized for targeted extracellular matrix remodeling in tissue engineering applications?

Recombinant Xenopus tll2 offers potential applications in tissue engineering:

  • Controlled ECM modification:

    • Selective cleavage of specific ECM components by tll2

    • Temporal control of matrix remodeling during scaffold development

    • Creation of gradients of ECM modification to guide cell migration and differentiation

  • Growth factor modulation:

    • Regulated activation of latent growth factors through tll2-mediated processing

    • Creation of BMP signaling gradients by controlled chordin cleavage

    • Engineering feedback loops between ECM remodeling and growth factor availability

  • Experimental design considerations:

    • Immobilize recombinant tll2 on scaffolds for localized activity

    • Develop light- or temperature-sensitive variants for spatiotemporal control

    • Create chimeric proteins with tissue-targeting domains for specific matrix remodeling

  • Potential applications:

    • Neural tissue engineering guided by BMP gradient establishment

    • Cartilage and bone tissue engineering through controlled collagen processing

    • Vascular engineering through specific basement membrane modifications

These applications leverage the natural role of Tolloid proteases in tissue patterning and ECM assembly for precisely controlled tissue engineering approaches .

What opportunities exist for developing tll2-based biosensors to monitor extracellular matrix dynamics?

Developing tll2-based biosensors would enable real-time monitoring of ECM dynamics:

  • FRET-based sensors:

    • Design substrate peptides with donor-acceptor fluorophore pairs

    • Cleavage by tll2 separates fluorophores, changing FRET signal

    • Incorporate into cell culture systems or in vivo for dynamic monitoring

  • Split reporter systems:

    • Engineer complementary reporter fragments joined by tll2-specific cleavage sites

    • Cleavage leads to separation or reconstitution of reporter activity

    • Can be designed to generate fluorescent, luminescent, or colorimetric outputs

  • Activity-based probes:

    • Develop chemical probes that covalently bind the active site of tll2

    • Binding changes probe properties (fluorescence, membrane permeability)

    • Enables spatiotemporal mapping of active tll2 in complex systems

  • Advanced applications:

    • High-throughput screening for tll2 inhibitors or enhancers

    • In vivo imaging of ECM remodeling during development or disease

    • Real-time monitoring of tissue engineering scaffold evolution

These biosensor approaches would provide unprecedented insights into the dynamics of tll2 activity and ECM remodeling in developmental and tissue engineering contexts .

What are the most promising approaches for structure-function studies of tll2 to develop specific inhibitors or activators?

For structure-function studies aimed at developing tll2 modulators:

  • Structural biology approaches:

    • X-ray crystallography of tll2 catalytic domain with inhibitors

    • Cryo-EM of full-length tll2 in various conformational states

    • NMR studies of individual domains and their interactions with modulators

    • Molecular dynamics simulations to identify allosteric sites

  • High-throughput screening:

    • Develop fluorogenic substrates for rapid activity assays

    • Screen natural product libraries for specific inhibitors

    • Fragment-based drug discovery targeting the metalloprotease domain

    • Virtual screening based on homology models aligned with known Tolloid structures

  • Rational design strategies:

    • Target the metal-binding HEXXH motif for competitive inhibitors

    • Develop domain-specific antibodies that modulate activity

    • Design protein-based inhibitors based on natural substrates

    • Create peptide mimetics that occupy the substrate-binding cleft

  • Validation approaches:

    • Test candidate molecules in purified enzyme assays

    • Evaluate cellular activity using reporter systems

    • Assess developmental effects in Xenopus embryos

    • Compare specificity across different Tolloid family members

These multidisciplinary approaches would facilitate the development of specific modulators for both research and potential therapeutic applications targeting tll2-mediated processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.